Arcus Biosciences News

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the

Businesswire04:35

Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript

Yahoo Finance03:48

Earnings Call Summary | Arcus Biosciences(RCUS.US) Q1 2024 Earnings Conference

The following is a summary of the Arcus Biosciences, Inc. (RCUS) Q1 2024 Earnings Call Transcript:Financial Performance:Arcus Biosciences reported that they have over $1 billion of cash on hand, which

Futu NewsMay 9 22:02 · Conference Call

Arcus Biosciences Price Target Maintained With a $30.00/Share by Wedbush

Arcus Biosciences Price Target Maintained With a $30.00/Share by Wedbush

Dow JonesMay 9 21:00

Wedbush: The Arcus Biosciences (RCUS.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $30.00.

Wedbush: The Arcus Biosciences (RCUS.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $30.00.

Zhitong FinanceMay 9 20:50

Wedbush Reiterates Outperform on Arcus Biosciences, Maintains $30 Price Target

Wedbush analyst Robert Driscoll reiterates Arcus Biosciences (NYSE:RCUS) with a Outperform and maintains $30 price target.

BenzingaMay 9 20:50

Arcus Biosciences Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 87.5% Wedbush → $30 Reiterates Outperform → Outperform 03/25/2024 212.5% Truist Securities → $5

BenzingaMay 9 20:49

Analysts Are Bullish on Top Healthcare Stocks: Olema Pharmaceuticals (OLMA), Arcus Biosciences (RCUS)

TipRanksMay 9 20:04

Wedbush Reaffirms Their Buy Rating on Arcus Biosciences (RCUS)

TipRanksMay 9 20:02

Arcus Biosciences: Holding Steady Amidst Progress and Uncertainties

TipRanksMay 9 18:05

Analysts Offer Insights on Healthcare Companies: Editas Medicine (EDIT), Arcus Biosciences (RCUS) and Maravai Lifesciences Holdings (MRVI)

TipRanksMay 9 15:30

Arcus Biosciences, Inc. (RCUS) Q1 2024 Earnings Call Transcript

Arcus Biosciences, Inc. (RCUS) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 9 09:55

Arcus Biosciences Q1 2024 GAAP EPS $(0.05) Beats $(0.98) Estimate, Sales $145.000M Beat $33.862M Estimate

Arcus Biosciences (NYSE:RCUS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.98) by 94.9 percent. This is a 95.41 percent increase over losses of $(1.0

BenzingaMay 9 05:31

Arcus Biosciences | 10-Q: Quarterly report

Futu NewsMay 9 04:15 · Announcements

Arcus Biosciences 1Q Rev $145M >RCUS

Arcus Biosciences 1Q Rev $145M >RCUS

Dow JonesMay 9 04:09

Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M

04:03 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M

MT NewswiresMay 9 04:03

Arcus Biosciences 1Q Loss $4M >RCUS

Arcus Biosciences 1Q Loss $4M >RCUS

Dow JonesMay 9 04:02

Arcus Biosciences 1Q Loss/Shr 5c >RCUS

Arcus Biosciences 1Q Loss/Shr 5c >RCUS

Dow JonesMay 9 04:02

Press Release: Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update

Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update -- Arcus data will be disclosed in two oral presentations at the 2024 American Society of Clini

Dow JonesMay 9 04:02

Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know

Yahoo FinanceMay 1 22:01